Overview

BioMavericks Ltd. is a biotech start-up founded in June 2021 in London, UK. We aim to provide bespoke data solutions for preclinical research. To achieve this aim, we work in partnership with clinicians and scientists to translate their genomic data into insights, helping them achieve their goals in a variety of areas such as immuno-oncology, cell & gene therapies, and regenerative medicine. At BioMavericks, we never purely describe data sets but highlight implications that lead to clinical applications. We combine all advanced wet-lab techniques and dry-lab algorithms to help you make groundbreaking discoveries. Currently, we are partnering with UCL and TestAVec to conduct preclinical projects in the early diagnosis of pancreatic cancer and targeted therapy for liver carcinogenesis, respectively.